NASDAQ: ATEC | Healthcare / Medical Devices & Instruments / USA |
17.10 | 0 | 0.00 | Vol 307.69K | 1Y Perf 335.07% |
Apr 13th, 2021 14:49 DELAYED |
BID | 17.06 | ASK | 17.10 | ||
Open | 17.05 | Previous Close | 17.10 | ||
Pre-Market | - | After-Market | - | ||
- -% | - - |
Target Price | 18.60 | Analyst Rating | Strong Buy 1.00 | |
Potential % | 8.71 | Finscreener Ranking | ★★ 46.86 | |
Insiders Trans % 3/6/12 mo. | -100/-100/-100 | Value Ranking | ★+ 45.40 | |
Insiders Value % 3/6/12 mo. | -100/-100/-100 | Growth Ranking | ★+ 44.01 | |
Insiders Shares Cnt. % 3/6/12 mo. | -100/-100/-100 | Income Ranking | — - | |
Market Cap | 1.63B | Earnings Rating | Strong Sell | |
Price Range Ratio 52W % | 85.86 | Earnings Date | 10th May 2021 |
Today's Price Range 16.6517.31 | 52W Range 3.3819.36 | 5 Year PE Ratio Range -2.00-0.4000 |
Summary:
Buy
Technical Indicators: | Neutral |
Moving Averages: | Strong Buy |
Performance | |||
---|---|---|---|
1 Week | 6.67% | ||
1 Month | 2.03% | ||
3 Months | 22.23% | ||
6 Months | 66.83% | ||
1 Year | 335.07% | ||
3 Years | 381.69% | ||
5 Years | 547.73% | ||
10 Years | 475.76% |
Mngmt Effectiveness | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
ROE (5Y Avg) | -633.53 | |||
ROE last 12 Months | -89.07 | |||
ROA (5Y Avg) | -20.01 | |||
ROA last 12 Months | -35.40 | |||
ROC (5Y Avg) | - | |||
ROC last 12 Months | -73.31 | |||
Return on invested Capital Q | -19.29 | |||
Return on invested Capital Y | -51.17 | |||
Assets Turnover | 0.50 | |||
Receivables Turnover | 5.30 |
Valuation | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
-14.70 | ||||
12.73 | ||||
14.18 | ||||
6.40 | ||||
-32.70 | ||||
-0.69 | ||||
18.12 | ||||
1.37 | ||||
1.59B | ||||
Forward PE | -53.33 | |||
PEG | - |
Financial Strength | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
2.30 | ||||
3.20 | ||||
0.23 | ||||
0.33 | ||||
-5.40 | ||||
Leverage Ratio | 2.90 |
Profitability | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
70.80 | ||||
-45.90 | ||||
-37.90 | ||||
-34.90 | ||||
-50.26 |
Revenue | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
114.75M | ||||
1.21 | ||||
15.91 | ||||
-5.31 |
Dividends | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
- | ||||
- | ||||
- | ||||
- | ||||
Payout ratio | - |
Earnings History | Estimate | Reported | Surprise % |
---|---|---|---|
Q04 2020 | -0.23 | -0.35 | -52.17 |
Q03 2020 | -0.25 | -0.18 | 28.00 |
Q02 2020 | -0.29 | -0.25 | 13.79 |
Q01 2020 | -0.20 | -0.33 | -65.00 |
Q04 2019 | - | -0.28 | - |
Q03 2019 | -0.23 | -0.22 | 4.35 |
Q02 2019 | -0.16 | -0.21 | -31.25 |
Q01 2019 | -0.20 | -0.20 | 0.00 |
Earnings Per End | Estimate | Revision % | Trend |
---|---|---|---|
3/2021 QR | -0.19 | -46.15 | Negative |
6/2021 QR | -0.19 | -90.00 | Negative |
12/2021 FY | -0.69 | -7.81 | Negative |
12/2022 FY | -0.33 | 25.00 | Positive |
Next Report Date | 10th May 2021 |
Estimated EPS Next Report | -0.19 |
Estimates Count | 4 |
EPS Growth Next 5 Years % | - |
Volume Overview | |
---|---|
Volume | 307.69K |
Shares Outstanding | 95.15M |
Trades Count | 3.28K |
Dollar Volume | 7.97M |
Avg. Volume | 704.14K |
Avg. Weekly Volume | 589.61K |
Avg. Monthly Volume | 810.05K |
Avg. Quarterly Volume | 699.24K |
Alphatec Holdings Inc. (NASDAQ: ATEC) stock closed at 17.1 per share at the end of the most recent trading day (a -2.84% change compared to the prior day closing price) with a volume of 346.80K shares and market capitalization of 1.63B. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Medical Devices & Instruments industry, Healthcare sector and employs 227 people. Alphatec Holdings Inc. CEO is Patrick S Miles.
The one-year performance of Alphatec Holdings Inc. stock is 335.07%, while year-to-date (YTD) performance is 17.77%. ATEC stock has a five-year performance of 547.73%. Its 52-week range is between 3.38 and 19.36, which gives ATEC stock a 52-week price range ratio of 85.86%
Alphatec Holdings Inc. currently has a PE ratio of -14.70, a price-to-book (PB) ratio of 12.73, a price-to-sale (PS) ratio of 14.18, a price to cashflow ratio of 6.40, a PEG ratio of 2.32, a ROA of -35.40%, a ROC of -73.31% and a ROE of -89.07%. The company’s profit margin is -50.26%, its EBITDA margin is -37.90%, and its revenue ttm is $114.75 Million , which makes it $1.21 revenue per share.
Of the last four earnings reports from Alphatec Holdings Inc., there were 2 positive earnings surprise and 2 negative earnings surprise. The company has EPS estimate of $-0.19 for the next earnings report. Alphatec Holdings Inc.’s next earnings report date is 10th May 2021.
The consensus rating of Wall Street analysts for Alphatec Holdings Inc. is Strong Buy (1), with a target price of $18.6, which is +8.71% compared to the current price. The earnings rating for Alphatec Holdings Inc. stock is Strong Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
Alphatec Holdings Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.
Alphatec Holdings Inc. has a Buy technical analysis rating based on Technical Indicators (ADX : 13.77, ATR14 : 1.10, CCI20 : 26.12, Chaikin Money Flow : 0.03, MACD : 0.33, Money Flow Index : 35.35, ROC : 2.52, RSI : 52.25, STOCH (14,3) : 52.72, STOCH RSI : 0.44, UO : 50.23, Williams %R : -47.28), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of Alphatec Holdings Inc. in the last 12-months were: Craig Hunsaker (Sold 62 731 shares of value $540 579 ), David P. Sponsel (Sold 89 999 shares of value $852 291 ), James L.L. Tullis (Option Excercise at a value of $2 728 722), James L.L. Tullis (Sold 263 776 shares of value $3 485 506 ), Jeffrey G. Black (Sold 45 929 shares of value $600 843 )
Analyst Ratings | Current | 1 M ago | 3 M ago |
---|---|---|---|
Strong Buy | |||
Moderate Buy | |||
Hold | |||
Moderate Sell | |||
Strong Sell | |||
Summary Rating | Strong Buy | Strong Buy | Strong Buy |
Alphatec Holdings Inc is a medical technology company focused on the design, development, and advancement of products for the surgical treatment of spinal disorders. The firm's spine approach technologies include Posterior Cervical Fusion, Anterior Cervical Discectomy and Fusion, Lateral Interbody Fusion, and Posterior Lumbar Interbody Fusion among others.
CEO: Patrick S Miles
Telephone: +1 760 431-9286
Address: 5818 El Camino Real, Carlsbad 92008, CA, US
Number of employees: 227
Copyright © 2016-2021 Finscreener.org. All Rights Reserved.
Disclaimer: Before deciding to trade you should carefully consider your investment objectives, level of experience and your risk appetite. Forex and Tradegate data is a real-time with a 30 second refresh. Prices may not be accurate and may differ from the actual market price. Prices on the website are indicative and solely for informational purposes, not for trading purposes or advice. Please be aware of the risks associated with trading the on financial markets, it is one of the riskiest investment forms. Past performance does not guarantee future profits. We take no responsibility for any losses that may arise as a result of the data contained on this website. The content and the website are provided "as is", without any warranties. In no event will Finscreener.org, its employees, owners, directors, affiliates, partners, data provider, third party or anyone else liable to anyone else for any decision made regarding information on this website.
All rights reserved. Financial Market Data powered by Quotemedia.com. All rights reserved. View the Terms of Use. CBOE BZX (BATS) real-time data for Premium users, NYSE/NYSE MKT (AMEX) data delayed 20 minutes. NASDAQ and other data delayed 15 minutes unless otherwise indicated. Technology and data provided by TeleTrader. Conditions of Use. The regulations of the respective stock are to be observed. Copyright © 2021. All market data is provided by Barchart Solutions. Futures: at least a 10 minute delay. Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. To see all exchange delays and terms of use, please see disclaimer. The Cryptocurrency Market real-time data provided by Cryptocompare.com
Don´t have an account? Register
Looks like you are using AdBlock.
The revenue earned from advertising enables us to provide the quality content you are trying to reach on this website. In order to view this page, please disable AdBlock or purchase Premium.
Sign in if you already have Premium account.
This could take some time, please wait.